Companies: 10,795·Total market cap: $144.5T
Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc.

BUGVFOTCHealthcare
$0.00
$-0.00(-24.29%)
Market Cap$26
P/E Ratio—
52W High$0.000001
52W Low$0.000001
Overview

Primo Nutraceuticals Inc. (BUGVF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BUGVF · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$3.83
No earnings history available.
No analyst estimates available for BUGVF.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: BUGVF ends December

Primo Nutraceuticals Inc. (BUGVF) reports earnings quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. The next BUGVF earnings date is expected around September 1, 2026.

Each quarter, investors track BUGVF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BUGVF revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BUGVF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

BUGVF earnings · 3 questions

Primo Nutraceuticals Inc.'s next earnings report is expected around September 1, 2026. BUGVF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BUGVF historically reports after market close (AMC).

BUGVF earnings datewhen is BUGVF earningsBUGVF next earnings datewhen does BUGVF report earningsBUGVF earnings calendar

▸ Source: FMP · Primo Nutraceuticals Inc. SEC filings · US GAAP · Primo Nutraceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026